Trend Innovations Holding Inc. announced that its Board of Directors has appointed Kenneth L. Waggoner as Trend's Chief Executive Officer (CEO) effective immediately. Trend has named Mr. Waggoner to head the Company's day-to-day operations and provide its strategic direction and corporate focus. Mr. Waggoner has 45 years of experience in management, business operations, and law.

He is a well-known attorney and recognized leader in the biotechnology, telecommunications, and chemical petroleum industries. Now, he will apply his business expertise to strengthen Trend's management team and its focus on product development and product pipeline. Most recently, Mr. Waggoner served as the CEO, President, and General Counsel of PharmaCyte Biotech Inc. between 2013 and 2022 where he guided the company's clinical development programs in pancreatic cancer, diabetes, and malignant ascites.

During that time, he was also the Chairman of the Board. Mr. Waggoner secured Orphan Drug designation for the company's pancreatic cancer treatment and was responsible for working with the US Food and Drug Administration to submit an Investigational New Drug application to begin a late-phase clinical trial in pancreatic cancer. Through Mr. Waggoner's leadership, PharmaCyte saw value creation with its uplisting to Nasdaq having previously traded on the OTCQB.

Simultaneous with the Nasdaq listing, Mr. Waggoner raised approximately $90 million to support PharmaCyte's worldwide operations and research and development efforts. Prior to his tenure at PharmaCyte, Mr. Waggoner was senior partner with Brobeck, Phleger and Harrison, named one of the top two law firms in the world that provide services to technology clients, such as Chiron, Amgen, Biogen Idec, Sangamo, Ligand, DepoTech and many others. He also served as a member of Brobeck's Executive Committee for numerous years managing Brobeck's worldwide operations, and Mr. Waggoner was also the Managing Partner of its Los Angeles office.

Further highlights of Mr. Waggoner's career include leadership and legal positions with several start-up companies as well as working with Fortune 500 companies, like Chevron. He served as the Vice President and General Counsel of Chevron's global downstream operations. There, he was responsible for the overall management of legal services to Chevron's Technology Company, Shipping Company, and its North American, Latin American, European, and Asian products companies.

While at Chevron, he also led the successful restructuring of Chevron's global Legal Department following Chevron's acquisition of Texaco. Mr. Waggoner received his Juris Doctorate with honors from Loyola University School of Law in Los Angeles and his Bachelor of Arts degree in Political Science with honors from California State University at Long Beach. Natalija Tunevic resigned as CEO of the company but will continue to serve as president and a director of the company.